CSF tau and Aβ42 levels in patients with Down’s syndrome
- 10 April 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (7) , 979-980
- https://doi.org/10.1212/wnl.56.7.979
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer's diseaseNeurobiology of Aging, 2000
- Amyloid ? protein species in cerebrospinal fluid and in brain from patients with Down's syndromeAnnals of Neurology, 1999
- Increased plasma amyloid β protein 1–42 levels in Down syndromeNeuroscience Letters, 1998
- CSF tau is related to apolipoprotein E genotype in early Alzheimer's diseaseNeurology, 1998
- Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndromeNature Medicine, 1996
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985